Researchers at Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI) today presented study results in which they conclude that a combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC).
Non-small cell lung carcinoma (NSCLC) is characterized by a remarkable variety of genomic alterations and point…
Feb 02, 12 02:30PM
|
0 comments



Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.